The Diagnostic Imaging AI (artificial intelligence) focus page provides information, videos, podcasts, and the latest news about product developments, trial results, screening guidelines, and protocol guidance that touch on the development and use of AI across the healthcare continuum.
April 25th 2025
Offering expedited calculation of prostate volume, Clarius Prostate AI is reportedly the first AI-enabled prostate measurement tool to garner FDA clearance for use with handheld ultrasound.
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
43rd Annual CFS: Innovative Cancer Therapy for Tomorrow®
November 12-14, 2025
Register Now!
20th Annual New York Lung Cancers Symposium®
November 15, 2025
Register Now!
Annual Hawaii Cancer Conference
January 24-25, 2026
Register Now!
43rd Annual Miami Breast Cancer Conference®
March 5-8, 2026
Register Now!
19th Annual New York GU Cancers Congress™
March 13-14, 2026
Register Now!
Mastering Advances in Managing Unresectable and Metastatic NSCLC—Immunotherapy, Targeted Therapies, and Emerging Strategies
View More
(CME Credit) Advancing Outcomes in Limited-Stage Small Cell Lung Cancer: From Evidence to Practice
View More
Current Insights on AI, Breast Cancer Screening and the FDA
November 8th 2022In a recently published article, researchers from Yale University discuss the pros and cons of current FDA regulations as they apply to the clearance and use of adjunctive artificial intelligence (AI) software with conventional breast cancer screening modalities such as mammography.
Deep Learning Improves CT Guidance for Revascularization of Coronary Total Occlusions
October 31st 2022Emerging research revealed that a deep learning model had a nearly twofold increase in successful segmentation and reconstruction of coronary total occlusions (CTOs) on coronary computed tomography angiogram (CCTA) and a 73 percent reduction in post-processing and measurement time in comparison to a conventional manual approach.
Can AI-Powered Virtual Biopsies Improve Detection of Breast Lesion Subtypes on Digital Mammography?
October 27th 2022In separate test sets of Israeli women and United States women who had either ductal carcinoma in situ or invasive breast cancer, emerging artificial intelligence (AI) algorithms achieved an area under the curve (AOC) of 88 percent and 80 percent, respectively, for malignancy detection.
Philips Gets FDA Nod for MRI Head and Neck Radiotherapy Application
October 20th 2022For physicians performing radiotherapy treatment of soft tissue tumors in the head and neck, the MRCAT Head and Neck offers an artificial intelligence (AI) application that allows the use of magnetic resonance imaging (MRI) as the primary or sole imaging for procedure planning.
HeartFlow Garners FDA Clearances for Two AI-Powered Assessment Tools with CCTA
October 20th 2022Plaque Analysis and RoadMap Analysis, two artificial intelligence (AI)-enabled assessment products, may enhance clinical evaluation of coronary artery disease (CAD) on cardiac computed tomography angiography (CCTA).
What Would the Perfect AI Do for This Radiologist?
October 10th 2022While artificial intelligence (AI) models have been acknowledged for aiding imaging analysis or facilitating workflow enhancements, this author envisions AI as a potential workstation conceierge capable of turning common venting and gripes into actionable items for significant improvements.
Adjunctive AI Software for Brain MRI Gets FDA Clearance for Assessing High-Grade Gliomas
October 10th 2022Incorporating artificial intelligence (AI)-based technology, Neosoma HGG reportedly demonstrated a 95.5 percent accuracy rate in measuring brain tumor volume on brain magnetic resonance imaging (MRI) scans at various points during the treatment of patients with high-grade gliomas.
Flash Versus Function: Does the AI Focus in Radiology Compromise Our Infrastructure Needs?
October 3rd 2022Addressing upgrades of traditional infrastructure used in everyday radiology practice may be a more practical use of resources than investment in artificial intelligence (AI) technology that is still evolving.
MRI Deep Learning Software from GE Healthcare Gets Expanded FDA Clearance
September 29th 2022AIR Recon DL, a deep learning-based image reconstruction software, will now be available with 3D sequences as well as PROPELLER motion-insensitive sequences on magnetic resonance imaging (MRI) scanners from GE Healthcare.
Could a New Deep Learning Tool Enhance CT Detection of Pancreatic Cancer?
September 13th 2022New research reveals that an emerging deep learning tool had comparable sensitivity and specificity to radiologist assessment of contrast-enhanced computed tomography (CT) scans for pancreatic cancer, and a 74.7 percent sensitivity rate for tumors smaller than 2 cm.
CT AI Software for Fracture Risk Gets Breakthrough Device Designation from FDA
September 13th 2022Assessing high-resolution computed tomography (CT) scans of the wrist, CurveBeam AI’s OssView software reportedly enables clinicians to ascertain bone fragility and fracture risk for women over the age of 70.
Samsung Gets FDA Nod for Versatile V7 Ultrasound System
September 9th 2022Offering uniform high-resolution images through a combination of beamforming and enhanced image processing, the new ultrasound platform reportedly has an array of diagnostic features ranging from cardiovascular applications to breast lesion assessment.
Study: Deep Learning System is Comparable to Radiologist Assessment of Chest X-Rays for Tuberculosis
September 7th 2022Examining imaging data of patients from multiple countries, researchers found that a deep learning system demonstrated higher sensitivity and non-inferior specificity for detecting active tuberculosis on chest radiographs in comparison to nine radiologist reviewers.
Emerging AI CT Tool May Provide Viable Complement to Lung-RADS Classification
September 6th 2022Researchers suggest that an artificial intelligence (AI)-powered risk stratification tool for lung nodules identified on computed tomography (CT) scans may identify likely malignancies more than one year prior to definitive diagnosis.
Study Suggests AI Improves Chest X-Ray Interpretation
September 2nd 2022Researchers found that stand-alone use of an artificial intelligence (AI) model led to a 24.9 percent increase in sensitivity for diagnosing pulmonary nodules and a 21.4 percent increase in sensitivity for diagnosing pneumonia.
Study Suggests AI is Superior to Sonographer Assessment of Heart Function on Echocardiograms
September 1st 2022In comparison to initial sonographer assessment of echocardiograms, cardiologists are over 10 percent less likely to change initial artificial intelligence (AI) assessment of left ventricular ejection fraction (LVEF), according to new research recently presented at the European Society of Cardiology Congress in Barcelona, Spain.